Detection of Alterations in the Gut Microbiota and Intestinal Permeability in Patients With Hashimoto Thyroiditis

dc.contributor.authorCayres, Leonardo César de Freitas
dc.contributor.authorde Salis, Larissa Vedovato Vilela [UNESP]
dc.contributor.authorRodrigues, Guilherme Siqueira Pardo
dc.contributor.authorLengert, André van Helvoort
dc.contributor.authorBiondi, Ana Paula Custódio
dc.contributor.authorSargentini, Larissa Donadel Barreto
dc.contributor.authorBrisotti, João Luiz
dc.contributor.authorGomes, Eleni [UNESP]
dc.contributor.authorde Oliveira, Gislane Lelis Vilela [UNESP]
dc.contributor.institutionSchool of Health Sciences Dr. Paulo Prata
dc.contributor.institutionUniversidade Estadual Paulista (Unesp)
dc.contributor.institutionBarretos Cancer Hospital
dc.date.accessioned2021-06-25T10:55:56Z
dc.date.available2021-06-25T10:55:56Z
dc.date.issued2021-03-05
dc.description.abstractHashimoto thyroiditis (HT) is the most common autoimmune disease worldwide, characterized by chronic inflammation and circulating autoantibodies against thyroid peroxidase and thyroglobulin. Patients require hormone replacement with oral levothyroxine, and if untreated, they can develop serious adverse health effects and ultimately death. There is a lot of evidence that the intestinal dysbiosis, bacterial overgrowth, and increased intestinal permeability favor the HT development, and a thyroid–gut axis has been proposed, which seems to impact our entire metabolism. Here, we evaluated alterations in the gut microbiota in Brazilian patients with HT and correlated this data with dietary habits, clinical data, and systemic cytokines and zonulin concentrations. Stool samples from 40 patients with HT and 53 controls were analyzed using real-time PCR, the serum cytokine levels were evaluated by flow cytometry, zonulin concentrations by ELISA, and the dietary habits were recorded by a food frequency questionnaire. We observed a significant increase (p < 0.05) in the Bacteroides species and a decrease in Bifidobacterium in samples of patients with HT. In addition, Lactobacillus species were higher in patients without thyroid hormone replacement, compared with those who use oral levothyroxine. Regarding dietary habits, we demonstrated that there are significant differences in the consumption of vegetables, fruits, animal-derived proteins, dairy products, saturated fats, and carbohydrates between patients and control group, and an inverse correlation between animal-derived protein and Bacteroides genus was detected. The microbiota modulation by diet directly influences the inflammatory profile due to the generated microbiota metabolites and their direct or indirect action on immune cells in the gut mucosa. Although there are no differences in systemic cytokines in our patients with HT, we detected increased zonulin concentrations, suggesting a leaky gut in patients with HT. These findings could help understand the development and progression of HT, while further investigations to clarify the underlying mechanisms of the diet–microbiota–immune system axis are still needed.en
dc.description.affiliationMicrobiome Study Group School of Health Sciences Dr. Paulo Prata
dc.description.affiliationMicrobiology Program Institute of Biosciences Humanities and Exact Sciences (IBILCE) São Paulo State University (UNESP)
dc.description.affiliationBarretos Cancer Hospital
dc.description.affiliationFood Engineering and Technology Department Institute of Biosciences Humanities and Exact Sciences São Paulo State University (UNESP) São José do Rio Preto
dc.description.affiliationUnespMicrobiology Program Institute of Biosciences Humanities and Exact Sciences (IBILCE) São Paulo State University (UNESP)
dc.description.affiliationUnespFood Engineering and Technology Department Institute of Biosciences Humanities and Exact Sciences São Paulo State University (UNESP) São José do Rio Preto
dc.description.sponsorshipFundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)
dc.identifierhttp://dx.doi.org/10.3389/fimmu.2021.579140
dc.identifier.citationFrontiers in Immunology, v. 12.
dc.identifier.doi10.3389/fimmu.2021.579140
dc.identifier.issn1664-3224
dc.identifier.scopus2-s2.0-85102871234
dc.identifier.urihttp://hdl.handle.net/11449/207485
dc.language.isoeng
dc.relation.ispartofFrontiers in Immunology
dc.sourceScopus
dc.subjectautoimmune disease
dc.subjectdietary habits
dc.subjectgut microbiota
dc.subjectHashimoto thyroiditis
dc.subjectinflammatory cytokines
dc.subjectintestinal dysbiosis
dc.subjectintestinal permeability
dc.titleDetection of Alterations in the Gut Microbiota and Intestinal Permeability in Patients With Hashimoto Thyroiditisen
dc.typeArtigo
unesp.campusUniversidade Estadual Paulista (Unesp), Instituto de Biociências Letras e Ciências Exatas, São José do Rio Pretopt
unesp.departmentBiologia - IBILCEpt
unesp.departmentEngenharia e Tecnologia de Alimentos - IBILCEpt

Arquivos